Back to Top

Benchling for Antibody R&D


Aug 24, 2021


Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates continue to push the envelope of antibody efficacy and safety. But the industry requires a new kind of digital solution that can offer a holistic view of antibody research and development, integrating large and disparate data sets to extract timely insights, while providing complete traceability to sequences, cell lines, and production processes. Learn how Benchling improves antibody R&D productivity and increases collaboration by 95%.

Application File

Benchling for Antibody R&D.pdf